Dr Reddys Gets US FDA Nod for Generic HIV Drug
Dr Reddys has received tentative US FDA approval for a generic version of a breakthrough HIV prevention drug. The treatment will target low- and middle-income countries with significantly lower pricing, aiming to expand global access.
Xurve View
Insights:
Xurve View
Dr. Reddy's Laboratories-ADR secured tentative United States Food and Drug Administration approval for a generic HIV prevention drug, targeting 120 lower-income nations.
